Supplementary Table 2 from EPHA2 Is a Predictive Biomarker of Resistance and a Potential Therapeutic Target for Improving Antiepidermal Growth Factor Receptor Therapy in Colorectal Cancer

MLA

Erika Martinelli, et al. Supplementary Table 2 from EPHA2 Is a Predictive Biomarker of Resistance and a Potential Therapeutic Target for Improving Antiepidermal Growth Factor Receptor Therapy in Colorectal Cancer. Apr. 2023. EBSCOhost, https://doi.org/10.1158/1535-7163.22505422.v1.

APA

Erika Martinelli, Fortunato Ciardiello, Maria Sibilia, Giuseppe Signoriello, Daniele Rizzi, Tiziana Pia Latiano, Evaristo Maiello, Virginia Tirino, Anna Maria Rachiglio, Nicola Normanno, Veronica Moreno-Viedma, Mariel C. Paul, Vincenzo Desiderio, Gianpaolo Papaccio, Vincenzo Sforza, Nunzia Matrone, Floriana Morgillo, Carminia Maria Della Corte, Davide Ciardiello, … Giulia Martini. (2023). Supplementary Table 2 from EPHA2 Is a Predictive Biomarker of Resistance and a Potential Therapeutic Target for Improving Antiepidermal Growth Factor Receptor Therapy in Colorectal Cancer. https://doi.org/10.1158/1535-7163.22505422.v1

Chicago

Erika Martinelli, Fortunato Ciardiello, Maria Sibilia, Giuseppe Signoriello, Daniele Rizzi, Tiziana Pia Latiano, Evaristo Maiello, et al. 2023. “Supplementary Table 2 from EPHA2 Is a Predictive Biomarker of Resistance and a Potential Therapeutic Target for Improving Antiepidermal Growth Factor Receptor Therapy in Colorectal Cancer,” April. doi:10.1158/1535-7163.22505422.v1.